Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Rasmussen

Showing results (381-390 of 389) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 389 results.
Genetic Epidemiology|November 30, 2011
Pitfalls of merging GWAS data: lessons learned in the eMERGE network and quality control procedures to maintain high data qualityRebecca L Zuvich, Loren L Armstrong, Suzette J Bielinski, et al.
Nature Biotechnology|November 26, 2013
Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study dataJoshua C Denny, Lisa Bastarache, Marylyn D Ritchie, et al.
Plos One|February 22, 2017
Genome-wide study of resistant hypertension identified from electronic health recordsLogan Dumitrescu, Marylyn D Ritchie, Joshua C Denny, et al.
Scientific Reports|February 3, 2023
Evaluation of the portability of computable phenotypes with natural language processing in the eMERGE networkJennifer A Pacheco, Luke V Rasmussen, Ken Wiley, et al.
Clinical Pharmacology and Therapeutics|June 25, 2014
Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systemsL J Rasmussen-Torvik, S C Stallings, A S Gordon, et al.
BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.
Multiple Sclerosis and Related Disorders|June 11, 2021
The effectiveness of natalizumab vs fingolimod-A comparison of international registry studiesJohanna B Andersen, Sifat Sharmin, Mathilde Lefort, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 20, 2026
Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort studyIzanne Roos, Sifat Sharmin, Dana Horakova, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 9, 2023
Returning integrated genomic risk and clinical recommendations: The eMERGE studyJodell E Linder, Aimee Allworth, Harris T Bland, et al.
Pageof 39

Showing results (381-390 of 389) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 389 results.
Genetic Epidemiology|November 30, 2011
Pitfalls of merging GWAS data: lessons learned in the eMERGE network and quality control procedures to maintain high data qualityRebecca L Zuvich, Loren L Armstrong, Suzette J Bielinski, et al.
Nature Biotechnology|November 26, 2013
Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study dataJoshua C Denny, Lisa Bastarache, Marylyn D Ritchie, et al.
Plos One|February 22, 2017
Genome-wide study of resistant hypertension identified from electronic health recordsLogan Dumitrescu, Marylyn D Ritchie, Joshua C Denny, et al.
Scientific Reports|February 3, 2023
Evaluation of the portability of computable phenotypes with natural language processing in the eMERGE networkJennifer A Pacheco, Luke V Rasmussen, Ken Wiley, et al.
Clinical Pharmacology and Therapeutics|June 25, 2014
Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systemsL J Rasmussen-Torvik, S C Stallings, A S Gordon, et al.
BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.
Multiple Sclerosis and Related Disorders|June 11, 2021
The effectiveness of natalizumab vs fingolimod-A comparison of international registry studiesJohanna B Andersen, Sifat Sharmin, Mathilde Lefort, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 20, 2026
Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort studyIzanne Roos, Sifat Sharmin, Dana Horakova, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 9, 2023
Returning integrated genomic risk and clinical recommendations: The eMERGE studyJodell E Linder, Aimee Allworth, Harris T Bland, et al.
Pageof 39